“Evaluation of the CRISPR/Cas9 system as genome editing platform for the Mucopolysaccharidosis IV A using a strategy for induction of higher homologous recombination frequency”, Univ. Sci., vol. 30, pp. 82–106, Apr. 2025, doi: 10.11144/.